Longitude Capital — 2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

Axonics Modulation TechnologiesApr 2017SEC filingmedium confidence

Irvine, US

Michael Williamson(Executive Officer)Dan L. Dearen(Executive Officer)Michael V. Williamson(Executive Officer)Raymond W. Cohen(Executive Officer, Director)

BoardDarren Cai(Director)Raphael Wisniewski(Director)

Board seatJuliet Bakker· per SEC Form D · $55.1M raise · filed Apr 2018

Amphora MedicalJul 2017

HealthtechMaple Grove, US

Tom Ressemann(Executive Officer, Director)

BoardMichael Liang(Director)Robert Weisskoff(Director)inDan Sachs(Director)

Co-investorsF-Prime Capital Baird Capital HBM Healthcare Investments

Helomicshelomics.com inMay 2017acquired by Predictive Oncology

AI & Machine LearningBiotechHealthtechPittsburgh, US

GERALD J. VARDZEL JR.(Executive Officer, Director)DOUGLAS ARMSTRONG(Executive Officer, Director)

BoardROBERT D. KEYSER JR.(Director)RICHARD AULICINO(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.